East Value Research GmbH
  • About
  • Services
  • Partners
  • Portfolio
  • Imprint
  • Privacy Policy
  • Research
  • Blog

East Value Research

About


We are a leading, management-owned research boutique with a focus on companies from Europe. Our role is that of an intermediary between companies on the one hand and investors on the other.

Our research products are directly distributed to more than 200 mutual and pension funds, family offices and independent asset managers from Central and Eastern Europe, the German-speaking region, Scandinavia, France and UK. In addition, we publish our reports on platforms such as Thomson Reuters, Capital IQ, Factset, Researchpool.com, rsrchxchange.com, ERI-C.com, Visiblealpha.com, ISBNews and PAP, thus ensuring that they are available to institutions from around the world. By organising roadshows and conferences, we provide investors with direct access to corporate decision makers.

Our team consists of professionals with long capital market experience in both Western Europe and the CEE region.


Team


Adrian-Kowollik

 

Adrian Kowollik

Adrian Kowollik is Managing Partner at East Value Research and the analyst covering the sectors Technology/Media/Telecom, IT, E-Commerce and Health Care. He graduated in Business Administration from Humboldt University in Berlin and has more than 8 years of experience in equity research and corporate finance. Adrian, who grew up in both Poland and Germany, is a strong believer in the concept of broker-independent equity research and the advantages, which it provides to both companies and investors.
Linkedin profile

Mateusz Pudlo (Analyst)

Mateusz Pudlo is Analyst. He has a Bachelors‘s degree in Accounting and Finance from the Wroclaw Business School and a Master’s degree in Economics and Business from Erasmus School of Economics in Rotterdam. His tasks include the preparation of sector reports, company analyses and valuations. Previously, he worked as Assistant in Accounting at EY (Polish branch). 

Yusuf Bilgic (Advisor)

Yusuf Bilgic is Advisor to East Value Research. During his impressive career, he was among others Managing Director, Head of Equity Sales & Equity Sales Trading at Lampe Capital in London (previously, part of the German Oetker Group); Director Equity Sales at the oldest German private bank Bankhaus Metzler in Frankfurt; and Vice President Cash Equity Sales Trading at Banco Santander in Frankfurt. Among his clients were institutional investors incl. long/short hedge funds from continental Europe, UK and the United Arab Emirates. Yusuf is based in London. 

Michael Lexa (Advisor)

Michael Lexa is Advisor to East Value Research. He looks back at a successful career as Equity Sales among others at Centrobanca, Julius Baer and Dresdner Bank. Over the last 30 years, Michael, who is based in Milan, has been introducing Italian listed companies to DACH-based institutional investors.  


Services



photo-red

Research

We provide broker-independent research on companies that are headquartered in Europe. Our main focus is on small-, micro- and nanocaps, an area, which is usually below the radar of typical brokerage houses. Scientific studies have shown that broker-independent research can be very helpful for companies when it comes to increasing their market visibility and liquidity.

In addition to analysis of single companies, which can be either sponsored or fully independent, we also offer sector reports, whereby we leverage our sector expertise and knowledge of markets in Western and Eastern Europe. Investors can gain access to all our past and future research reports through 1. the relevant research platforms and 2. by purchasing a yearly subscription on our website.

Roadshows

For the companies, which we cover, we organise international roadshows. Thus, we provide them with access to new investor groups and help to diversify the shareholder structure. Through our broker partners, we can also act as an intermediary in capital market transactions.

Consulting for Start-ups

In addition to services for listed companies, we also offer advisory for European start-ups, especially when it comes to raising capital in CEE and Western markets.

Valuation Services & Corporate Finance

Our offering is complemented by valuation services as well as corporate finance advisory, which we are able to offer our clients through our partnership with the Berlin-based firm InveSP Capital Partners. InveSP Capital Partners provides M&A, restructuring and financing advisory services for smaller companies from Western and Eastern Europe. In the last years, it has completed transactions worth EUR >1bn, many of which were crossborder deals.


Imprint


East Value Research GmbH
Gontardstr. 11
10178 Berlin
Germany
Tel.: +49 30 20609082

E-Mail: kontakt@eastvalueresearch.com
Represented by: Adrian Kowollik
Commercial Register: Registration at Amtsgericht (District Court) Berlin-Charlottenburg under the registration number HRB 164473 B.
VAT-Id: DE298268078

Copyrights
All rights reserved. Reproduction, commercial redistribution and entry into commercial databases are only allowed with the written consent of East Value Research GmbH.

Liability
This website www.eastvalueresearch.com has been prepared with the greatest possible care. However, East Value Research GmbH cannot guarantee that the information contained herein is correct or precise. Any liability for damages, which result directly or indirectly from the use of this website, will not be assumed if it is not intentional or reckless. If there are links to external websites, East Value Research GmbH will not take the responsibility for their content.

Conflicts of interest
East Value Research GmbH has taken several measures to prevent conflicts of interest. One of these is that its employees are prohibited to trade in stocks from its coverage that is being sponsored e.g. by issuers.
In addition, its employees are not permitted to accept gifts or any other beneficial contributions from individuals, who have an interest in the content of our research publications.


Partners


ResearchPool Logo - September 2015

RSRCHX
Alphavalue-logo

ERI-C Logo
Visiblealpha

INVESP_Logo_schmall_WHQ


 

 

 

 


Blog


IPO Analysis: CSG NV – A defence giant from CEE

24/01/2026

Business description

Since 1995, when its predecessor Excalibur Army was founded by Mr. Jaroslav Strnad—the father of its current CEO and owner—the Czechoslovak Group (CSG) has grown organically and through acquisitions into a global operation with more than 100 subsidiaries and over 14,000 employees. Today, the Group, which is based in Prague, is a rapidly growing European defence and industrial conglomerate with operations spanning three segments: Defence Systems, Ammo+, and Others.

In the Defence Systems segment, the company develops, produces, and sells military and special wheeled and tracked vehicles (e.g., Pandur 8×8 EVO infantry vehicle), temporary bridge systems (especially AM 70 EX and AM 50 EX),  special weapon systems, medium/large-calibre ammunition (where the company is No. 1 in Europe, e.g., through its Spanish subsidiary FMG Granada) for combat vehicles, artillery, tanks, and small arms, as well as equipment for pyrotechnic services. In addition, the companies in this division produce e.g. radars, complex air traffic control systems, situation awareness tools for general aviation, and anti-drone systems.

The Ammo+ segment basically comprises the operations of the US-based Kinetic Group—which, with brands such as Remington, CCI, Speer, and Hevi-Shot, is a leading producer of small-calibre ammunition with revenues exceeding USD 1.5bn (CSG acquired it in 2024 for USD 2.2bn)—and the 100%-owned Italian company Fiocchi, the No. 3 worldwide in small-calibre ammunition production, with facilities in Italy, the UK, and the US. In this segment, CSG is the No 1 worldwide.

The Others segment mainly comprises:

1. TATRA TRUCKS, the third oldest car manufacturer in the world with more than 170 years of tradition in the production of vehicles, which focuses on heavy vehicles for extreme terrain and the worst climatic conditions with a unique chassis concept.

2. DAKO-CZ, one of the three largest European manufacturers of brake systems and components for the world’s leading manufacturers and operators of rail vehicles.

3. Armi Perazzi, an Italian company with a history of >60 years that specialises in the production of high-quality hunting and sporting shotguns.

In 2024, CSG’s Defence Systems segment dominated with a share of 66.4% (EUR 3.4bn) in total revenues (incl. Kinetic Group total Group revenues equalled EUR 5.1bn, without EUR 4bn) and a 73.5% share in total EBITDA (EUR 987m). The Ammo+ segment accounted for EUR 1.66bn of revenues and EUR 343m of EBITDA and Others for EUR 77m and EUR 19m respectively.

In terms of geographical markets, Europe accounted for 68% of revenues (thereof: Ukraine 33.1%), USA 25.8%, and the rest of the world 6.2%. 61% came from NATO countries. With c. 40 production facilities in Czechia, Slovakia, US, Germany, UK, Italy, Serbia, Spain, and India, the Group distributes its products to key long-term customers, ranging from government bodies (mainly NATO members) to leading companies in >70 countries worldwide.

IPO

On January 23, 2026, CSG was listed on the Euronext Amsterdam at a share price of EUR 25, which implied a market capitalisation of EUR 25bn. During the IPO its CEO Michal Strnad sold 102.17m shares (plus potentially 19.83m as part of the over-allotment) worth in total max. EUR 3bn. In addition, the company issued 30m new shares worth EUR 724m net, which will be used for expansion incl. several acquisitions. Cornerstone investors such as Artisan Partners, BlackRock and Quatar’s Al-Rayyan Holding committed EUR 900m (EUR 300m each, in total 36m shares with no lock-up).

After the IPO, Mr Strnad will own via his vehicle CSG FIN a.s. 86.77% of the shares without the full over-allotment and 84.78% if the over-allotment option will be fully exercised. His shares will be subject to a 360-day lock-up period.

Financials

Between 2022 and 2024, CSG (without accounting for Kinetic Group) grew its revenues from EUR 1bn to EUR 4bn, implying a CAGR of 98.7%. Over the same period, the EBITDA margin increased from 18.8% to 26.9% and net income from EUR 141.1m to EUR 633.4m. With a total backlog of EUR 14bn (2.8 x LTM Q3/25 revenues) and a pipeline under negotiation of EUR 32bn (6.6x) – thereof EUR 17bn mid/large calibre ammo, EUR 9bn land systems, EUR 4bn defence electronic, EUR 2bn small calibre ammo – revenues reached EUR 4.5bn in 9M/25 (+82.4%, +29.8% y-o-y if Kinetic Group’s contribution is accounted for in 9M/24, 76% share of Defense Systems, 22% Ammo+, 2% Others), the EBITDA margin 26.4% and net profit from continuing operations EUR 511.5m (+22.5%). Net debt equalled EUR 3.59bn, however it will be reduced by the IPO proceeds.

In terms of guidance, for 2025E management forecasts revenues of EUR >6.4bn and an adjusted operating EBIT margin of 24-25% (in 9M/25, it equalled 24.5%). For 2026E, revenues are expected to be in the range of EUR 7.4-7.6bn at an unchanged adjusted operating EBIT margin y-o-y. The main reason for the growth in 2026E is supposed to be the Group’s Land Systems and M&L Ammo units of CSG Defence Systems segment as well as a recovery in Ammo+. Over the medium term, CSG targets mid-teens organic revenue CAGR.

Summary & Conclusion

An estimated EBITDA of EUR 2bn in 2026E would translate into a 2026E EV/EBITDA multiple of 17.6x at present. This is significantly below the 24.1x of German Rheinmetall, the 19.2x of RENK, and the 20.7x of Hensoldt, but higher than the 13.3x of Italian Leonardo, whose EBITDA margins and ROCE are however significantly below those of CSG. Thus, we believe that CSG’s current valuation remains attractive. In addition, management targets a payout ratio of 30–40% of annual net profit starting in 2027E, based on 2026E results.

The defence industry—especially in Europe—remains highly attractive given the threat from Russia and NATO’s target for defence spending, which is expected to increase from 2.76% on average in 2025 to 5% by 2035E. According to various sources, the global military sector is expected to grow from approx. USD 2.8tr in 2025 to USD 4.7–6.6tr by 2035E, with Europe and Asia-Pacific as the fastest-growing regions.

The main risks are that a large portion of CSG’s revenues depends on obtaining and maintaining export licenses and that a peace treaty in Ukraine would likely negatively affect defence stock valuations.

NewConnect – The “Polish NASDAQ”

10/12/2025

History & recent developments

NewConnect was launched on 30 August 2007 as an alternative market of the Warsaw Stock Exchange for young, innovative companies with high growth potential. From the start, it was intended to offer young companies an easy and inexpensive way to become publicly traded. In its early years, the NewConnect segment grew rapidly — in a record-breaking 2011, 172 companies made their debut. After several scandals that caused significant losses for investors, the market is currently undergoing revitalization, including segmentation such as NC Focus for high-quality companies and simplification of information procedures.

Sources: Google search, East Value Research

Current market statistics

Currently, the website www.newconnect.pl lists 356 companies from various sectors, thereof 5 foreign ones. Their total market capitalisation equals PLN 13.3bn. On December 9, trading turnover equalled PLN 5m/EUR 1.18m, with Sygnis S.A. (PLN 467k, Sector: Additive production technologies), Scanway S.A. (PLN 381k, Sector: Space) and Grupa Niewiadow-PGM (PLN 401k, Sector: Defense) being the most traded stocks. In Q3/25, the total trading turnover amounted to PLN 672.7m/EUR 159m.

Below is a list of the 10 largest NewConnect companies by market cap:

Sources: stooq.pl, bankier.pl, company websites, East Value Research GmbH

Success stories and controversies

There are a number of companies that debuted on the NewConnect segment—often to raise equity capital for growth because the VC sector is underdeveloped in Poland—over the years grew their business and valuation significantly, and finally moved to the regulated main market of the Warsaw Stock Exchange. Examples include Synektik S.A., a distributor of diagnostic and therapeutic devices and producer of radiopharmaceuticals; Voxel S.A., the leading operator of diagnostic imaging centers in Poland and distributor of medical devices and IT solutions; Spyrosoft S.A., an IT outsourcing company with operations in 10 countries on 4 continents; Selvita S.A., which today — after the spin-off of Ryvu Therapeutics — is the leading Polish biotechnology group; and PGS Software S.A., another IT outsourcing company, which in 2021 was aquired by a Dutch private equity group.

Sources: Google search, East Value Research GmbH

On the other hand, there are also multiple examples of NewConnect-listed companies that do not meet basic corporate governance standards, delay the release of financial reports, and have very low daily trading volume, which makes it difficult to buy or sell larger positions. In recent years, the Warsaw Stock Exchange has put stronger focus on eliminating these pathologies.

Recommendation for investors

Although they can generate significant returns for shareholders, we believe that investments in the NewConnect segment require a very profound due diligence of the company’s business models, their management teams and shareholders. We recommend to commit only a small fraction of the portfolio value to these companies.

 

Investment idea: Wirtualna Polska Holding S.A. (Market cap PLN 1.63bn/EUR 385.3m)

13/11/2025

Buy a EUR 1.99 subscription to view all premium blog posts

>>> Visit blog page


KONTAKT

East Value Research GmbH
Gontardstr. 11
10178 Berlin

kontakt@eastvalueresearch.com
www.eastvalueresearch.com

  • About
  • Services
  • Partners
  • Portfolio
  • Imprint
  • Privacy Policy
  • Research
  • Blog
Twitter LinkedIn
Design by Kometa Studio